Molecular diagnosis of putative Stargardt Disease probands by exome sequencing
- PMID: 22863181
- PMCID: PMC3459799
- DOI: 10.1186/1471-2350-13-67
Molecular diagnosis of putative Stargardt Disease probands by exome sequencing
Abstract
Background: The commonest genetic form of juvenile or early adult onset macular degeneration is Stargardt Disease (STGD) caused by recessive mutations in the gene ABCA4. However, high phenotypic and allelic heterogeneity and a small but non-trivial amount of locus heterogeneity currently impede conclusive molecular diagnosis in a significant proportion of cases.
Methods: We performed whole exome sequencing (WES) of nine putative Stargardt Disease probands and searched for potentially disease-causing genetic variants in previously identified retinal or macular dystrophy genes. Follow-up dideoxy sequencing was performed for confirmation and to screen for mutations in an additional set of affected individuals lacking a definitive molecular diagnosis.
Results: Whole exome sequencing revealed seven likely disease-causing variants across four genes, providing a confident genetic diagnosis in six previously uncharacterized participants. We identified four previously missed mutations in ABCA4 across three individuals. Likely disease-causing mutations in RDS/PRPH2, ELOVL, and CRB1 were also identified.
Conclusions: Our findings highlight the enormous potential of whole exome sequencing in Stargardt Disease molecular diagnosis and research. WES adequately assayed all coding sequences and canonical splice sites of ABCA4 in this study. Additionally, WES enables the identification of disease-related alleles in other genes. This work highlights the importance of collecting parental genetic material for WES testing as the current knowledge of human genome variation limits the determination of causality between identified variants and disease. While larger sample sizes are required to establish the precision and accuracy of this type of testing, this study supports WES for inherited early onset macular degeneration disorders as an alternative to standard mutation screening techniques.
Similar articles
-
Evaluation of the ELOVL4, PRPH2 and ABCA4 genes in patients with Stargardt macular degeneration.Mol Med Rep. 2012 Nov;6(5):1045-9. doi: 10.3892/mmr.2012.1063. Epub 2012 Sep 4. Mol Med Rep. 2012. PMID: 22948568
-
ABCA4 and ROM1: implications for modification of the PRPH2-associated macular dystrophy phenotype.Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4253-65. doi: 10.1167/iovs.09-4655. Epub 2010 Mar 24. Invest Ophthalmol Vis Sci. 2010. PMID: 20335603
-
Phenotypic features of CRB1-associated early-onset severe retinal dystrophy and the different molecular approaches to identifying the disease-causing variants.Graefes Arch Clin Exp Ophthalmol. 2016 Sep;254(9):1833-9. doi: 10.1007/s00417-016-3358-2. Epub 2016 Apr 25. Graefes Arch Clin Exp Ophthalmol. 2016. PMID: 27113771
-
Inherited macular dystrophies and differential diagnostics.Medicina (Kaunas). 2012;48(9):485-95. Medicina (Kaunas). 2012. PMID: 23168924 Review.
-
[Genotype-Phenotype Correlations in Patients with CRB1 Mutations].Klin Monbl Augenheilkd. 2017 Mar;234(3):289-302. doi: 10.1055/s-0043-103961. Epub 2017 Mar 29. Klin Monbl Augenheilkd. 2017. PMID: 28355663 Review. German.
Cited by
-
Comprehensive analysis of patients with Stargardt macular dystrophy reveals new genotype-phenotype correlations and unexpected diagnostic revisions.Genet Med. 2015 Apr;17(4):262-70. doi: 10.1038/gim.2014.174. Epub 2014 Dec 4. Genet Med. 2015. PMID: 25474345 Free PMC article.
-
Targeted next-generation sequencing identifies ABCA4 mutations in Chinese families with childhood-onset and adult-onset Stargardt disease.Biosci Rep. 2021 Jun 25;41(6):BSR20203497. doi: 10.1042/BSR20203497. Biosci Rep. 2021. PMID: 33988224 Free PMC article.
-
Reduced penetrance in a large Caucasian pedigree with Stickler syndrome.Ophthalmic Genet. 2017 Jan-Feb;38(1):43-50. doi: 10.1080/13816810.2016.1275018. Epub 2017 Jan 17. Ophthalmic Genet. 2017. PMID: 28095098 Free PMC article.
-
Intravitreal Use of a Bone Marrow Mononuclear Fraction (BMMF) Containing CD34+ Cells in Patients with Stargardt Type Macular Dystrophy.Stem Cells Int. 2020 Dec 10;2020:8828256. doi: 10.1155/2020/8828256. eCollection 2020. Stem Cells Int. 2020. PMID: 33488737 Free PMC article.
-
Evaluation of autosomal dominant retinal dystrophy genes in an unaffected cohort suggests rare or private missense variants may often be benign.Mol Vis. 2013 May 6;19:980-5. Print 2013. Mol Vis. 2013. PMID: 23687434 Free PMC article.
References
-
- Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A, Chidambaram A, Gerrard B, Baird L, Stauffer D, Peiffer A. et al.A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997;15(3):236–246. doi: 10.1038/ng0397-236. - DOI - PubMed
-
- Coco RM, Tellería JJ, Sanabria MR, Rodríguez-Rúa E, García MT. PRPH2 (Peripherin/RDS) mutations associated with different macular dystrophies in a Spanish population: a new mutation. Eur J Ophthalmol. 2010;20(4):724–732. - PubMed